These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24333976)

  • 1. [Evolution of sentinel lymph node biopsy in breast cancer--axillary staging in the past 15 years at the Uzsoki Street Hospital].
    Mersich T; Faludi S; Ping O; Jóbaházi J; Szabó B; Dede K; Besznyák I; Bursics A
    Magy Seb; 2013 Dec; 66(6):320-4. PubMed ID: 24333976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sentinel lymph node status and axillary lymph node dissection in the surgical treatment of breast cancer].
    Cserni G
    Orv Hetil; 2014 Feb; 155(6):203-15. PubMed ID: 24486844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sentinel node biopsy and axillary clearence in early breast cancer--An algorithm with explanations and queries].
    Cserni G
    Magy Seb; 2016 Mar; 69(1):4-13. PubMed ID: 26901689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Review of national and international guidelines for sentinel lymph node biopsy and complementary axillary dissection in breast cancer].
    Vincent L; Margueritte F; Uzan J; Owen C; Seror J; Pouget N; Guillot E; Rouzier R
    Bull Cancer; 2017 Apr; 104(4):356-362. PubMed ID: 28214005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The importance of the extracapsular extension of the sentinel node metastasis in the surgical treatment of breast cancer].
    Maráz R; Venczel L; Sikorszki L; Ambrózay É; Serfőző O; Rajtár M; Cserni G
    Magy Seb; 2020 Mar; 73(1):16-22. PubMed ID: 32172574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
    Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
    Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a requirement for axillary lymph node dissection following identification of micro-metastasis or isolated tumour cells at sentinel node biopsy for breast cancer?
    Joyce DP; Solon JG; Prichard RS; Power C; Hill AD
    Surgeon; 2012 Dec; 10(6):326-9. PubMed ID: 22386798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy indications and controversies in breast cancer.
    Wiatrek R; Kruper L
    Maturitas; 2011 May; 69(1):7-10. PubMed ID: 21411254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
    Imoto S; Yamauchi C; Komoike Y; Tsugawa K; Yotsumoto D; Wada N; Ueno T; Oba MS; Shien T; Sugae S; Tsuda H; Yoneyama K
    Breast Cancer; 2017 May; 24(3):427-432. PubMed ID: 27553957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.
    Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R
    Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
    Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
    Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sentinel lymph nodes in breast cancer: some thoughts on the past and on the future in connection with the clinical practice at the Uzsoki Street Hospital].
    Cserni G
    Magy Seb; 2014 Feb; 67(1):26-7. PubMed ID: 24566658
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.
    Samphao S; Eremin JM; El-Sheemy M; Eremin O
    Ann Surg Oncol; 2008 May; 15(5):1282-96. PubMed ID: 18330650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trade-offs associated with axillary lymph node dissection with breast irradiation versus breast irradiation alone in patients with a positive sentinel node in relation to the risk of non-sentinel node involvement: implications of ACOSOG Z0011.
    Krishnan MS; Recht A; Bellon JR; Punglia RS
    Breast Cancer Res Treat; 2013 Feb; 138(1):205-13. PubMed ID: 23338762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.